RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3
- PMID: 29884911
- DOI: 10.1038/s41374-018-0071-2
RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3
Abstract
Epithelial-mesenchymal transition (EMT) plays a critical role in initiating tumor invasion and metastasis of colorectal cancer (CRC), although the underlying mechanisms remain to be clarified. Herein, we demonstrate that the active form of Rac family small GTPase 1 (RAC1-GTP) is overexpressed in CRCs and promotes the EMT-mediated invasion of CRC cells through activation of the signal transducers and activators of transcription 3 (STAT3) pathway. Increased expression of RAC1-GTP in CRC tissues was positively correlated with the TNM stages of CRCs and indicated poor prognosis of CRC patients. Targeting RAC1-GTP activity by its specific inhibitor NSC23766 markedly suppressed the migration and invasion of CRC cells. Mechanistically, RAC1-GTP directly interacted with STAT3 to promote STAT3 phosphorylation, thus promoted EMT of CRC cells. Enforced expression of constitutively activated STAT3 (STAT3-C) abrogated the suppressive effect of RAC1-GTP disruption on the migration and invasion of CRC cells. Importantly, NSC23766 disrupted EMT in CRC cells and significantly diminished growth of CRC xenografts. Taken together, our data indicate that RAC1-GTP is an important player in EMT-mediated tumor invasion and a potential therapeutic target for CRCs.
Similar articles
-
CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.Theranostics. 2020 Sep 2;10(24):11063-11079. doi: 10.7150/thno.45674. eCollection 2020. Theranostics. 2020. PMID: 33042270 Free PMC article.
-
Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.Exp Mol Pathol. 2019 Apr;107:57-67. doi: 10.1016/j.yexmp.2018.11.007. Epub 2018 Nov 19. Exp Mol Pathol. 2019. PMID: 30465755
-
Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.Oncotarget. 2016 Sep 27;7(39):64136-64147. doi: 10.18632/oncotarget.11636. Oncotarget. 2016. PMID: 27580057 Free PMC article.
-
Effects of NaV1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer.Cell Biochem Biophys. 2025 Jun;83(2):1483-1494. doi: 10.1007/s12013-024-01625-x. Epub 2024 Dec 14. Cell Biochem Biophys. 2025. PMID: 39673684 Free PMC article. Review.
-
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.Environ Res. 2023 Sep 15;233:116458. doi: 10.1016/j.envres.2023.116458. Epub 2023 Jun 20. Environ Res. 2023. PMID: 37348629 Review.
Cited by
-
The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance.Cancers (Basel). 2024 Jul 6;16(13):2472. doi: 10.3390/cancers16132472. Cancers (Basel). 2024. PMID: 39001533 Free PMC article. Review.
-
WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells.Mol Cell Biochem. 2024 Dec;479(12):3341-3354. doi: 10.1007/s11010-024-04937-x. Epub 2024 Feb 11. Mol Cell Biochem. 2024. PMID: 38341833
-
RAC1 Takes the Lead in Solid Tumors.Cells. 2019 Apr 26;8(5):382. doi: 10.3390/cells8050382. Cells. 2019. PMID: 31027363 Free PMC article. Review.
-
Rho GTPases in cancer radiotherapy and metastasis.Cancer Metastasis Rev. 2020 Dec;39(4):1245-1262. doi: 10.1007/s10555-020-09923-5. Epub 2020 Aug 8. Cancer Metastasis Rev. 2020. PMID: 32772212 Review.
-
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis.Int J Clin Oncol. 2023 Sep;28(9):1129-1138. doi: 10.1007/s10147-023-02374-2. Epub 2023 Jul 7. Int J Clin Oncol. 2023. PMID: 37418142
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous